Date(s) - 16 Jan 2020
4:00 pm - 5:00 pm
Dr Dennis Wang, PhD, Group Leader at the NIHR Sheffield Biomedical Research Centre, University of Sheffield, UK
Dr. Dennis Wang will discuss possible ways to enable ML methods to be more powerful for discovery and to reduce ambiguity within translational medicine, allowing data-informed decision-making to deliver the next generation of diagnostics and therapeutics to patients quicker, at lowered costs, and at scale.
The talk by Dr. Dennis Wang will be followed by a panel discussion with Mr. Albert Wang, M. Eng., Head, IT Business Partner, Translational Research & Technologies, Bristol-Myers Squibb.